Lynn E. Sullivan

5.6k total citations
54 papers, 4.4k citations indexed

About

Lynn E. Sullivan is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Lynn E. Sullivan has authored 54 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 29 papers in Public Health, Environmental and Occupational Health and 26 papers in Infectious Diseases. Recurrent topics in Lynn E. Sullivan's work include Opioid Use Disorder Treatment (28 papers), HIV/AIDS Research and Interventions (25 papers) and HIV, Drug Use, Sexual Risk (25 papers). Lynn E. Sullivan is often cited by papers focused on Opioid Use Disorder Treatment (28 papers), HIV/AIDS Research and Interventions (25 papers) and HIV, Drug Use, Sexual Risk (25 papers). Lynn E. Sullivan collaborates with scholars based in United States, Australia and Germany. Lynn E. Sullivan's co-authors include David A. Fiellin, Patrick G. O’Connor, Richard S. Schottenfeld, Jeanette M. Tetrault, Brent A. Moore, Marek C. Chawarski, William C. Becker, Declan T. Barry, Rani A. Desai and Srikanth C. Nallani and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Lynn E. Sullivan

54 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn E. Sullivan United States	35	2.6k	2.4k	900	698	628	54	4.4k
Gregorio Barrio Spain	32	2.7k 1.0×	2.3k 1.0×	527 0.6×	635 0.9×	825 1.3×	145	4.7k
Jennifer R. Havens United States	35	2.4k 0.9×	2.1k 0.9×	563 0.6×	910 1.3×	947 1.5×	137	4.3k
David C. Marsh Canada	38	3.0k 1.1×	3.2k 1.3×	426 0.5×	858 1.2×	782 1.2×	176	5.0k
Daniel Ciccarone United States	38	3.2k 1.2×	3.7k 1.5×	1.1k 1.2×	874 1.3×	791 1.3×	83	6.0k
Kanna Hayashi Canada	32	3.0k 1.1×	2.2k 0.9×	818 0.9×	493 0.7×	662 1.1×	275	4.1k
Elinore F. McCance‐Katz United States	42	2.1k 0.8×	2.2k 0.9×	791 0.9×	1.2k 1.8×	599 1.0×	116	5.6k
Christine L. Mattson United States	34	1.7k 0.7×	2.4k 1.0×	1.1k 1.2×	750 1.1×	621 1.0×	65	4.7k
Jo Kimber Australia	31	4.6k 1.8×	4.5k 1.9×	741 0.8×	1.3k 1.8×	676 1.1×	56	6.4k
Sarah Larney Australia	38	4.9k 1.9×	3.0k 1.3×	1.3k 1.5×	890 1.3×	783 1.2×	160	7.0k
Marek C. Chawarski United States	32	2.4k 0.9×	2.5k 1.0×	329 0.4×	727 1.0×	554 0.9×	96	3.8k

Countries citing papers authored by Lynn E. Sullivan

Since Specialization

Citations

This map shows the geographic impact of Lynn E. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn E. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn E. Sullivan more than expected).

Fields of papers citing papers by Lynn E. Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn E. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn E. Sullivan. The network helps show where Lynn E. Sullivan may publish in the future.

Co-authorship network of co-authors of Lynn E. Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn E. Sullivan. A scholar is included among the top collaborators of Lynn E. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn E. Sullivan. Lynn E. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tetrault, Jeanette M., et al.. (2013). Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment. Journal of Addiction Medicine. 7(2). 102–107. 7 indexed citations

Edelman, E. Jennifer, et al.. (2012). Human Immunodeficiency Virus Testing Practices Among Buprenorphine-prescribing Physicians. Journal of Addiction Medicine. 6(2). 159–165. 12 indexed citations

Berkenblit, Gail, James M. Sosman, Hirut Gebrekristos, et al.. (2012). Factors Affecting Clinician Educator Encouragement of Routine HIV Testing Among Trainees. Journal of General Internal Medicine. 27(7). 839–844. 19 indexed citations

Gowing, Linda, Michael Farrell, Reinhard Bornemann, Lynn E. Sullivan, & Robert Ali. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews. CD004145–CD004145. 235 indexed citations

Sullivan, Lynn E., Jeanette M. Tetrault, R. Scott Braithwaite, Barbara J. Turner, & David A. Fiellin. (2011). A Meta-analysis of the Efficacy of Nonphysician Brief Interventions for Unhealthy Alcohol Use: Implications for the Patient-Centered Medical Home. American Journal on Addictions. 20(4). 343–356. 56 indexed citations

Korthuis, P. Todd, Joseph Cofrancesco, Gail Berkenblit, et al.. (2011). Provider and Practice Characteristics Associated with Use of Rapid HIV Testing by General Internists. Journal of General Internal Medicine. 26(11). 1258–64. 6 indexed citations

Sullivan, Lynn E., Michael Botsko, Chinazo O. Cunningham, et al.. (2011). The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(Supplement 1). S54–S61. 27 indexed citations

Fiellin, David A., Linda Weiss, Michael Botsko, et al.. (2011). Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(Supplement 1). S33–S38. 74 indexed citations

Barry, Declan T., Kevin S. Irwin, Emlyn S. Jones, et al.. (2010). Opioids, Chronic Pain, and Addiction in Primary Care. Journal of Pain. 11(12). 1442–1450. 92 indexed citations

10.

Sullivan, Lynn E., Brent A. Moore, Patrick G. O’Connor, et al.. (2009). The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office‐Based Buprenorphine/Naloxone for the Treatment of Opioid Dependence. American Journal on Addictions. 19(1). 53–58. 55 indexed citations

11.

Fiellin, David A., Brent A. Moore, Lynn E. Sullivan, et al.. (2008). Long‐Term Treatment with Buprenorphine/Naloxone in Primary Care: Results at 2–5 Years. American Journal on Addictions. 17(2). 116–120. 136 indexed citations

12.

Gordon, Adam J., Lynn E. Sullivan, Daniel P. Alford, et al.. (2007). Update in Addiction Medicine for the Generalist. Journal of General Internal Medicine. 22(8). 1190–1194. 10 indexed citations

13.

Becker, William C., Lynn E. Sullivan, Jeanette M. Tetrault, Rani A. Desai, & David A. Fiellin. (2007). Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence. 94(1-3). 38–47. 328 indexed citations

14.

Barry, Declan T., Brent A. Moore, Michael V. Pantalon, et al.. (2007). Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment. Journal of General Internal Medicine. 22(2). 242–245. 61 indexed citations

15.

Sullivan, Lynn E., R. Douglas Bruce, Gregory M. Lucas, et al.. (2006). Initial Strategies for Integrating Buprenorphine into HIV Care Settings in the United States. Clinical Infectious Diseases. 43(Supplement_4). S191–S196. 30 indexed citations

16.

Crowley, David J., Ivan Boubriak, Brian R. Berquist, et al.. (2006). The uvrA, uvrB and uvrC genes are required for repair of ultraviolet light induced DNA photoproducts in Halobacterium sp. NRC-1.. PubMed. 2(1). 11–11. 71 indexed citations

17.

Sullivan, Lynn E., Marek C. Chawarski, Patrick G. O’Connor, Richard S. Schottenfeld, & David A. Fiellin. (2005). The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?. Drug and Alcohol Dependence. 79(1). 113–116. 97 indexed citations

18.

Gowing, Linda, Michael Farrell, Reinhard Bornemann, Lynn E. Sullivan, & Robert Ali. (2005). BRIEF REPORT: Methadone Treatment of Injecting Opioid Users for Prevention of HIV Infection. Journal of General Internal Medicine. 21(2). 193–195. 79 indexed citations

19.

Sullivan, Lynn E., David S. Metzger, Paul J. Fudala, & David A. Fiellin. (2005). Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction. 100(2). 150–158. 99 indexed citations

20.

Sullivan, Lynn E. & David A. Fiellin. (2004). Hepatitis C and HIV Infections: Implications for Clinical Care in Injection Drug Users. American Journal on Addictions. 13(1). 1–20. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact